Biogen, Sage win FDA priority review for depression therapy (NASDAQ:BIIB) | Seeking Alpha
Tremor drug by Sage, Biogen succeeds in trial, but investors question safety - Boston Business Journal
Biogen Gives Sage Therapeutics $1.5 Billion In Deal To Develop Depression And Tremor Treatments | The Healthcare Technology Report.
Sage/Biogen Announce Positive Results in Ph. 3 CORAL Depression Drug Trial - YouTube
Biogen and Sage Therapeutics in Global Collaboration – ISPE Boston
Sage/Biogen Announce Positive Results in Ph. 3 CORAL Depression Drug Trial
LinkedInのBiogen: Biogen and Sage Therapeutics Announce FDA Accepts Filing of New Drug…
NDA for Biogen-Sage's Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development - GeneOnline News
Sage-Biogen drug improves symptoms in postpartum depression study, Health News, ET HealthWorld
Biogen and Sage Therapeutics Share Update on FDA Advisory Committee for Zuranolone | Biogen
Sage, Biogen begin rolling submission with FDA for zuranolone to treat depression | Seeking Alpha
Sage Stock Rises on Postpartum Depression Drug Data | Barron's
Biogen and Sage get August PDUFA date for oral depression drug
Sage Therapeutics Archives - Drug Discovery and Development
FDA accepts NDA and grants priority review of Zuranolone from Sage Therapeutics, Biogen - Express Pharma
Sage and Biogen plan for zuranolone NDA filing
Sage, Biogen's tremor drug hits goal, but 38% of people drop out | Fierce Biotech
Biogen og Sage færdiggør løbende ansøgning til FDA for depressionsmiddel — MedWatch
Biogen makes risky bet on trial depression drug - The Boston Globe
Sage, Biogen show good results on zuranolone phase 3 depression trial - MedWorks Media
Sage and Biogen File NDA for Fast-Acting Postpartum Depression Drug – ISPE Boston
Sage Therapeutics Gets $1.53B From Biogen in a Collaboration Deal
Biogen, Sage Therapeutics get USFDA priority review for depression drug Zuranolone
Sage Therapeutics, Biogen Start Rolling Submission For Zuranolone In Major Depressive Disorder
Sage-Biogen drug improves symptoms in postpartum depression study | Reuters
